Temple University
Philadelphia, Pennsylvania, 19122, United States
Location status: Recruiting
NCT Number: NCT06257433
Participants will complete a treasure task during neuroimaging where they have to learn which keys open a treasure chest, and then they are tested on the contents of the treasure chest.
Interested in participating?
Request Info18 year–45 year
All sexes
Interventional
Not applicable
Philadelphia, Pennsylvania, 19122, United States
Location status: Recruiting
Study 2 will use a treasure task (employed in C.2.1.1), in which participants select amongst 3 keys to learn which feature of keys unlocks the treasure chest, revealing a trial unique object image (Fig. 8b). On each encoding trial participants view three multi-featural keys and a treasure chest. Each key varies on three dimensions: color (red, blue, yellow), shape of the handle (square, circle, triangle), and number of ridges (one, two, three). On each trial, all 9 dimensions of the keys are represented, but the dimensions represented on each key are randomized across trials. During hypothesis testing runs, participants are instructed to find the feature of a key that opens the treasure chest to reveal a trial-unique image. Critically, there is one target feature of a key that deterministically opens the treasure chest. The target feature of the key randomly changes after participants successfully open the chest 4 consecutive times. This design manipulates goal-oriented exploration by allowing participants to resolve uncertainty until they identify the target feature of the key. Uncertainty resolution is the greatest after the target features switches and incrementally reduces via individuals' active hypothesis testing. During control runs, participants will be instructed to select specific keys, and key selection and outcomes will be yolked to prior hypothesis testing runs. Participants will complete 3 runs of hypothesis testing runs and 3 control runs. Trial number for each run is determined by participant behavior, in that hypothesis testing runs end when participants complete 4 rule switches (~30 trials). Encoding is incidental in this task. Following encoding, participants will complete an immediate and delayed item memory test. On each trial, participants will view objects from the hypothesis testing and control conditions as well as new foil objects. Memory will be tested for half the stimuli immediately and at a 24-hour delay. These memory measures will be related to uncertainty resolution estimated by reinforcement learning, to determine how prior knowledge during information seeking has subsequent effects on memory.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants will be given cued instructions as to whether they are in a high or low motivation condition
Time frame: During Procedure
Functional Magnetic Resonance Imaging Activation characterizing Mesolimbic-Hippocampal Interactions
Time frame: 24-hours After Procedure
Item and Associative Memory for memoranda shown during the task
Contact information is provided by the study sponsor or research team.
Temple University
Other
The Influence of Mesolimbic-hippocampal Interactions on Episodic Memory During Active Information Seeking
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05929898
Behavior, Memory
Durham, North Carolina, United States
View Trial DetailsNCT07113067
Abulia, Apathy
Charleston, South Carolina, United States
View Trial DetailsNCT07676110
Agnosia, Anxiety Disorders
Fort Collins, Colorado, United States
View Trial DetailsNCT05065151
Basal Ganglia Diseases, Brain Diseases
San Francisco, California, United States
View Trial Details